June 30, 2011 — Results of a clinical research study at Sharp Memorial Hospital indicate that patients 70 years of age or older have good functional recovery, survival and quality of life at two years when undergoing left ventricular assist device (LVAD) therapy for heart failure. The study was released in the June 21 edition of the Journal of the American College of Cardiology.

June 29, 2011 – The University of Chicago is allowing Pinnacle Oncology to acquire its technology and intellectual property rights for the development of a compound, amifostine, to prevent genomic instability caused by a variety of sources of ionizing radiation exposure, including common computed tomography (CT) scans.

June 29, 2011 – The experimental antiplatelet drug ticagrelor prevented significantly more cardiovascular complications than the standard medication clopidogrel when used with low-dose aspirin, according to new research reported in the American Heart Association's Emerging Science Series webinar.

June 29, 2011 – An industry-first collaboration is bringing together cardiovascular testing company Atherotech Diagnostics Lab and diabetes testing company GlycoMark. The collaboration means the two companies will jointly commercialize the VAP (vertical auto profile) cholesterol test with the GlycoMark diabetes test.

June 29, 2011 — A device that could reduce key health risks facing kidney failure patients connected to dialysis machines has won a $10,000 first prize for Johns Hopkins graduate students in the 2011 American Society of Mechanical Engineers (ASME) Innovation Showcase.

If approved by the U.S. Food and Drug Administration (FDA) later this summer, transcatheter valve therapy (TVT) – an innovative procedure that uses minimally invasive catheter-based technology to repair heart valve disease much like stents with coronary arteries – will bring a new therapeutic option to older patients with aortic stenosis who either could not be treated before or are too high-risk for conventional surgical therapy.